title: Crimean-Congo hemorrhagic fever in children.
abstract: BACKGROUND
  Crimean-Congo hemorrhagic fever (CCHF) virus causes a severe disease in humans with a mortality up to 30%. In Turkey there has been an increase in the number of cases during years since 2002. Humans of all ages living in endemic areas,especially those who are working as shepherds and toddlers, have high risk of acquiring CCHF.
  
  
  OBJECTIVE
  The epidemiological, clinical, and laboratory characteristics of the children, who were diagnosed as Crimean-Congo hemorrhagic fever (CCHF) were described.
  
  
  METHODS
  The children infected with CCHF virus between April 2008 and October 2009, and hospitalised in Ankara Dişkapi Children's and Research Hospital were included.
  
  
  RESULTS
  Laboratory diagnosis was set by detection of CCHF IgM antibodies and/or genetic detection of CCHF virus. Thirtyone cases included to the study, and all were from the northeastern Anatolia and the southern parts of Black sea region. The mean age was 9.45+/-4.9 years, the proportion of females was 38.7%. The majority (87%) of the cases had the history of tick bite. There was no fatal case. All the patients had the history of fever. Malaise,tonsillopharyngitis, nausea-vomiting, headache, diarrhea, myalgia and rash were the most common symptoms. The mean AST and ALT levels on the admission were 116 (range 25-389) and 61 (range 8-180)U/L respectively. The mean platelet count on admission was 125,000/mm3, and the lowest was 23,000/mm3. The mean of the lowest white blood cell count was 2353/mm3 and the mean of the highest lactate dehydrogenase was 861IU/L.
  
  
  CONCLUSIONS
  The clinical course of CCHF among children seems to be milder than in adults. Tonsillopharyngitis is a common symptom among children with CCHF.
authors.affiliation: Department of Pediatrics, Republic of Turkey Ministry of Health Ankara Diskapi Children's and Research Hospital, Diskapi, and Hacettepe University Faculty of Medicine, Ankara, Turkey. hasantezer@yahoo.com
authors.forename: Hasan
authors.initials: H
authors.lastname: Tezer
authors.forename: Iclal Ayranci
authors.initials: IA
authors.lastname: Sucakli
authors.forename: Tulin Revide
authors.initials: TR
authors.lastname: Sayli
authors.forename: Elif
authors.initials: E
authors.lastname: Celikel
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Yakut
authors.forename: Ateş
authors.initials: A
authors.lastname: Kara
authors.forename: Bahattin
authors.initials: B
authors.lastname: Tunc
authors.forename: Onder
authors.initials: O
authors.lastname: Ergonul
mesh_terms: D000293:Adolescent; D000914:Antibodies, Viral / Q000097:blood; D002648:Child; D002675:Child, Preschool; D005260:Female; D003225:Hemorrhagic Fever Virus, Crimean-Congo / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D006479:Hemorrhagic Fever, Crimean / Q000175:diagnosis / Q000453:epidemiology* / Q000473:pathology*; D006760:Hospitalization; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D007223:Infant; D008297:Male; D010612:Pharyngitis / Q000821:virology; D012367:RNA, Viral / Q000097:blood; D014069:Tonsillitis / Q000821:virology; D014421:Turkey / Q000453:epidemiology
chemical_list: D000914:Antibodies, Viral; D007075:Immunoglobulin M; D012367:RNA, Viral
references.citation: Lancet Infect Dis. 2006 Apr;6(4):203-14
references.pmid: 16554245
references.citation: Ann Trop Paediatr. 2009 Mar;29(1):23-8
references.pmid: 19222930
references.citation: Clin Infect Dis. 2003 Oct 15;37(8):1139-42
references.pmid: 14523782
references.citation: J Med Microbiol. 2005 Apr;54(Pt 4):385-389
references.pmid: 15770025
references.citation: Clin Microbiol Infect. 2006 Jun;12(6):551-4
references.pmid: 16700704
references.citation: Pediatr Infect Dis J. 2008 Jun;27(6):561-3
references.pmid: 18434934
references.citation: Infection. 1997 Nov-Dec;25(6):364-7
references.pmid: 9427056
references.citation: Euro Surveill. 2008 Aug 14;13(33):
references.pmid: 18761892
references.citation: J Infect. 2006 Mar;52(3):207-15
references.pmid: 15953646
references.citation: Am J Trop Med Hyg. 1989 Nov;41(5):581-5
references.pmid: 2510529
references.citation: Scand J Infect Dis. 2007;39(4):332-6
references.pmid: 17454897
references.citation: Antiviral Res. 2004 Dec;64(3):145-60
references.pmid: 15550268
references.citation: Int J Infect Dis. 2008 Jul;12(4):374-9
references.pmid: 18063402
references.citation: Rev Infect Dis. 1989 May-Jun;11 Suppl 4:S794-800
references.pmid: 2749111
references.citation: Clin Infect Dis. 2004 Jul 15;39(2):284-7
references.pmid: 15307042
references.citation: J Infect. 2009 Oct;59(4):291-3
references.pmid: 19665801
references.citation: Int J Infect Dis. 2009 May;13(3):380-6
references.pmid: 18986819
references.citation: Chest. 2005 Jul;128(1):263-72
references.pmid: 16002945